Result: Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study

*Title*:

*Author/editor-in-chief*:

*Publication*:

Freiburg : Universität, 2022

*Physical description scale*:

1 Online-Ressource

*Format*:

*eBook*

*Language*:

*eng*

*Notes*:

European journal of cancer. - 175 (2022) , 204-213, ISSN: 1879-2995

*DOI*:

10.1016/j.ejca.2022.08.024

*Result*: Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study